Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2950 of 3284 entries
View as:

Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain

Phase: N/A Priority: Normal
NCT ID: NCT00998062 Org: User:
Start: 11/30/09 End: 10/31/11 Due: 10/31/12

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05809934 Org: User:
Start: 03/15/23 End: 09/17/25 Due: 09/17/26

Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00254787 Org: User:
Start: 06/30/05 End: 01/31/06 Due: 01/31/07

Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season

Phase: N/A Priority: Normal
NCT ID: NCT00688779 Org: User:
Start: 01/31/08 End: 04/30/09 Due: 04/30/10

Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00882518 Org: User:
Start: 04/30/09 End: 07/31/10 Due: 07/31/11

Ciclesonide for the Treatment of Airway Hyperresponsiveness

Phase: N/A Priority: Normal
NCT ID: NCT00826969 Org: User:
Start: 09/30/08 End: 10/31/11 Due: 10/31/12

Study to Assess Bronchospasm Potentially Induced by HFO vs HFA MDI in Participants With Well/Partially Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05850494 Org: User:
Start: 05/02/23 End: 08/21/23 Due: 08/21/24

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

Phase: N/A Priority: Normal
NCT ID: NCT06564844 Org: User:
Start: 10/15/24 End: 01/19/35 Due: 01/19/36

Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT05560607 Org: User:
Start: 08/12/22 End: 02/27/24 Due: 02/27/25

High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT01757275 Org: User:
Start: 02/28/13 End: 12/31/14 Due: 12/31/15

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT01750281 Org: User:
Start: 12/18/12 End: 10/31/22 Due: 10/31/23

Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed

Phase: N/A Priority: Normal
NCT ID: NCT05548777 Org: User:
Start: 09/15/22 End: 12/20/22 Due: 12/20/23

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05603845 Org: User:
Start: 02/20/23 End: 04/10/25 Due: 04/10/26

Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

Phase: N/A Priority: Normal
NCT ID: NCT03229122 Org: User:
Start: 12/26/16 End: 07/06/18 Due: 07/06/19

Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05107336 Org: User:
Start: 11/25/21 End: 03/21/23 Due: 03/21/24

Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens

Phase: N/A Priority: Normal
NCT ID: NCT04989816 Org: User:
Start: 08/20/21 End: 02/28/24 Due: 02/28/25

Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01354782 Org: User:
Start: 05/31/11 End: 09/30/11 Due: 09/30/12

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00351910 Org: User:
Start: 05/31/06 End: 04/30/07 Due: 04/30/08

US PRECISION Implementation Study

Phase: N/A Priority: Normal
NCT ID: NCT04891978 Org: User:
Start: 04/20/21 End: 04/30/23 Due: 04/30/24

AZD2066 Cocktail Study

Phase: N/A Priority: Normal
NCT ID: NCT00930306 Org: User:
Start: 06/30/09 End: 09/30/09 Due: 09/30/10

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

Phase: N/A Priority: Normal
NCT ID: NCT00842855 Org: User:
Start: 02/28/09 End: 11/30/10 Due: 11/30/11

Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability

Phase: N/A Priority: Normal
NCT ID: NCT01895946 Org: User:
Start: 12/31/13 End: 07/31/15 Due: 07/31/16

An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan

Phase: N/A Priority: Normal
NCT ID: NCT06156982 Org: User:
Start: 12/06/23 End: 01/09/24 Due: 01/09/25

A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06951880 Org: User:
Start: 06/27/25 End: 09/24/26 Due: 09/24/27

Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

Phase: N/A Priority: Normal
NCT ID: NCT00859560 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09